Mustang Bio, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for MBIO, updated each market day.
MBIO AI Sentiment
AI predicts Mustang Bio, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Mustang Bio, Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Sector
Exchange
Market Cap
$3,713,356
Cap Tier
Employees
4
Headquarters
WALTHAM, MA
Listed Since
Aug. 22, 2017
Website
MBIO Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
MBIO Volatility
Mustang Bio, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
